1. Ammann, R. W., Akovbiantz, A., Largiader, F. & Schueler, G. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 86, 820–828 (1984).
2. Ceyhan, G. O. et al. Pancreatic Neuropathy and Neuropathic Pain—A Comprehensive Pathomorphological Study of 546 Cases. Gastroenterology 136, 177-186.e1 (2009).
3. Yadav, D. & Lowenfels, A. B. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144, 1252–1261 (2013).
4. Singh, V. K., Yadav, D. & Garg, P. K. Diagnosis and Management of Chronic Pancreatitis: A Review. JAMA 322, 2422–2434 (2019).
5. Mayerle, J. et al. Genetics, Cell Biology, and Pathophysiology of Pancreatitis. Gastroenterology 156, 1951-1968.e1 (2019).
6. Sendler, M. et al. Cathepsin B Activity Initiates Apoptosis via Digestive Protease Activation in Pancreatic Acinar Cells and Experimental Pancreatitis. J. Biol. Chem. 291, 14717–14731 (2016).
7. Halangk, W. et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 106, 773–781 (2000).
8. Gukovsky, I., Gukovskaya, A. S., Blinman, T. A., Zaninovic, V. & Pandol, S. J. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am. J. Physiol. 275, G1402-1414 (1998).
9. Sendler, M. et al. Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut 62, 430–439 (2013).
10. Sendler, M. et al. Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice. Gastroenterology 154, 704-718.e10 (2018).
11. Gukovskaya, A. S. et al. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 122, 974–984 (2002).
12. Sendler, M. et al. Complement Component 5 Mediates Development of Fibrosis, via Activation of Stellate Cells, in 2 Mouse Models of Chronic Pancreatitis. Gastroenterology 149, 765-776.e10 (2015).
13. Xue, J. et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun 6, 7158 (2015).
14. Wu, J. et al. Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injury. EBioMedicine 58, 102920 (2020).
15. Criscimanna, A., Coudriet, G. M., Gittes, G. K., Piganelli, J. D. & Esni, F. Activated macrophages create lineage-specific microenvironments for pancreatic acinar- and β-cell regeneration in mice. Gastroenterology 147, 1106-1118.e11 (2014).
16. Rappolee, D. A., Mark, D., Banda, M. J. & Werb, Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 241, 708–712 (1988).
17. Nascimento, D. C. et al. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nat Commun 8, 14919 (2017).
18. Wynn, T. A. & Vannella, K. M. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity 44, 450–462 (2016).
19. Apte, M. V. et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44, 534–541 (1999).
20. Bachem, M. G. et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115, 421–432 (1998).
21. Gieseck, R. L., Wilson, M. S. & Wynn, T. A. Type 2 immunity in tissue repair and fibrosis. Nat. Rev. Immunol. 18, 62–76 (2018).
22. Sendler, M. et al. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis. Gastroenterology 158, 253-269.e14 (2020).
23. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151–1164 (1995).
24. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. & Yamaguchi, T. Regulatory T cells: how do they suppress immune responses? Int Immunol 21, 1105–1111 (2009).
25. Tiemessen, M. M. et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proceedings of the National Academy of Sciences 104, 19446–19451 (2007).
26. Watanabe, T., Kudo, M. & Strober, W. Immunopathogenesis of pancreatitis. Mucosal Immunol 10, 283–298 (2017).
27. Lahl, K. et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57–63 (2007).
28. Mchedlidze, T. et al. Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis. Immunity 39, 357–371 (2013).
29. Hams, E. et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proceedings of the National Academy of Sciences 111, 367–372 (2014).
30. Frost, F. et al. Impaired Exocrine Pancreatic Function Associates With Changes in Intestinal Microbiota Composition and Diversity. Gastroenterology 156, 1010–1015 (2019).
31. Beyer, G., Habtezion, A., Werner, J., Lerch, M. M. & Mayerle, J. Chronic pancreatitis. Lancet 396, 499–512 (2020).
32. Haber, P. S. et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am. J. Pathol. 155, 1087–1095 (1999).
33. Ansel, K. M., Djuretic, I., Tanasa, B. & Rao, A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24, 607–656 (2006).
34. Noval Rivas, M., Burton, O. T., Oettgen, H. C. & Chatila, T. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J Allergy Clin Immunol 138, 801-811.e9 (2016).
35. Kalekar, L. A. et al. Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses. Sci Immunol 4, (2019).
36. Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282–1295 (2013).
37. Kotsianidis, I. et al. Global Impairment of CD4 + CD25 + FOXP3 + Regulatory T Cells in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 179, 1121–1130 (2009).
38. Li, J., Tan, J., Martino, M. M. & Lui, K. O. Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration. Front Immunol 9, 585 (2018).
39. Claassen, M. A. A., de Knegt, R. J., Tilanus, H. W., Janssen, H. L. A. & Boonstra, A. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 52, 315–321 (2010).
40. Criscimanna, A. et al. Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology 141, 1451–1462, 1462.e1–6 (2011).
41. Patella, S., Phillips, D. J., Tchongue, J., de Kretser, D. M. & Sievert, W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 290, G137-144 (2006).
42. Yamashita, S., Maeshima, A., Kojima, I. & Nojima, Y. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 15, 91–101 (2004).
43. Hardy, C. L. et al. The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology. Immunol Cell Biol 93, 567–574 (2015).
44. Ohnishi, N. et al. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 52, 1487–1493 (2003).
45. Walton, K. L., Johnson, K. E. & Harrison, C. A. Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis. Front Pharmacol 8, 461 (2017).
46. Yasuda, H. et al. Activin A: negative regulator of amylase secretion and cell proliferation in rat pancreatic acinar AR42J cells. Am J Physiol 267, G220-226 (1994).
47. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634–648 (2012).
48. Gasteiger, G., Fan, X., Dikiy, S., Lee, S. Y. & Rudensky, A. Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981–985 (2015).
49. Lechner, A. J. et al. Recruited Monocytes and Type 2 Immunity Promote Lung Regeneration following Pneumonectomy. Cell Stem Cell 21, 120-134.e7 (2017).
50. Bouchery, T. et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun 6, 6970 (2015).
51. Krishnamoorthy, N. et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol 194, 863–867 (2015).
52. Berasain, C. et al. Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology 128, 424–432 (2005).
53. Zhou, Y. et al. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis. J Biol Chem 287, 41991–42000 (2012).
54. Tokumaru, S. et al. Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing. Journal of Cell Biology 151, 209–220 (2000).
55. Repertinger, S. K. et al. EGFR Enhances Early Healing After Cutaneous Incisional Wounding. Journal of Investigative Dermatology 123, 982–989 (2004).
56. Chen, J. et al. EGFR Signaling Promotes TGF β -Dependent Renal Fibrosis. JASN 23, 215–224 (2012).
57. Fuchs, B. C. et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma: Fuchs et al. Hepatology 59, 1577–1590 (2014).
58. Venkataraman, T., Coleman, C. M. & Frieman, M. B. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection. J Virol 91, (2017).
59. Diener, M. K. et al. Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial. Lancet 390, 1027–1037 (2017).